Citius Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 246.16 K | $221.56 K | 93.02% | 1.15% |
| 05/15/2026 | 167.74 K | $150.96 K | 100.00% | 0.78% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 77.76 K | $69.98 K | 100.00% | 0.36% |
| BLACKROCK, INC. | 05/13/2026 | 69.85 K | $62.87 K | 0.00% | 0.33% |
| HRT FINANCIAL LP | 05/14/2026 | 60.33 K | $54.00 K | 100.00% | 0.28% |
| 04/16/2026 | 59.01 K | $53.11 K | 0.00% | 0.27% | |
| UBS GROUP AG | 05/05/2026 | 55.03 K | $49.52 K | -28.01% | 0.26% |
| NORTHERN TRUST CORP | 05/14/2026 | 43.97 K | $39.58 K | 0.00% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 36.84 K | $33.15 K | 185.61% | 0.17% |
| CITADEL ADVISORS LLC | 05/15/2026 | 29.10 K | $26.19 K | -56.63% | 0.14% |
| LPL FINANCIAL LLC | 05/06/2026 | 25.05 K | $22.54 K | -0.09% | 0.12% |
| JANE STREET GROUP, LLC | 05/12/2026 | 23.90 K | $21.51 K | 100.00% | 0.11% |
| STATE STREET CORP | 05/15/2026 | 23.27 K | $20.94 K | 0.00% | 0.11% |
| JANE STREET GROUP, LLC | 05/12/2026 | 22.52 K | $20.27 K | 25.42% | 0.10% |
| XTX TOPCO LTD | 05/15/2026 | 21.30 K | $19.17 K | -80.12% | 0.10% |
| ARKADIOS WEALTH ADVISORS | 05/18/2026 | 20.00 K | $18.00 K | 0.00% | 0.09% |
| MILLER FINANCIAL SERVICES LLC | 05/04/2026 | 14.00 K | $12.60 K | 100.00% | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 13.14 K | $11.82 K | -78.40% | 0.06% |
| IFP ADVISORS, INC | 04/13/2026 | 7.08 K | $6.38 K | 0.00% | 0.03% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 6.52 K | $5.87 K | 62.24% | 0.03% |
| CITIGROUP INC | 05/11/2026 | 5.23 K | $4.71 K | 520.17% | 0.02% |
| CHELSEA COUNSEL CO | 06/04/2026 | 4.63 K | $4.16 K | 0.00% | 0.02% |
| QUENT CAPITAL, LLC | 04/28/2026 | 4.27 K | $3.84 K | 361.08% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 2.79 K | $2.51 K | -0.82% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 2.74 K | $2.46 K | 83.93% | 0.01% |
| CURIO WEALTH, LLC | 05/12/2026 | 2.00 K | $1.80 K | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 1.79 K | $1.61 K | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 1.36 K | $1.23 K | -32.87% | 0.01% |
| AMERITAS ADVISORY SERVICES, LLC | 05/12/2026 | 1.00 K | $900 | 100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 400 | $360 | 0.00% | 0.00% |
| ASSETMARK, INC | 05/06/2026 | 372 | $335 | 100.00% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 04/22/2026 | 160 | $144 | 0.00% | 0.00% |
| MURPHY & MULLICK CAPITAL MANAGEMENT CORP | 04/17/2026 | 160 | $144 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 04/22/2026 | 120 | $108 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 120 | $82 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 107 | $96 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 80 | $72 | 0.00% | 0.00% |
| FAIRSCALE CAPITAL, LLC | 05/11/2026 | 42 | $38 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 8 | $8 | 100.00% | 0.00% |
| BOGART WEALTH, LLC | 04/28/2026 | 4 | $4 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LUMINIST CAPITAL LLC | 04/24/2026 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Citius Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of Citius Pharmaceuticals Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 246,158
VANGUARD FIDUCIARY TRUST CO: 77,755
BlackRock, Inc.: 69,851
HRT FINANCIAL LP: 60,332
UBS Group AG: 55,025
NORTHERN TRUST CORP: 43,974
4.64% of Citius Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.18 M shares in the last 24 months. This purchase volume represents approximately $2.67 M in transactions.